The Life Sciences Report
Notable Quotes
"RP is going for a best-of-breed solution." (3/4/15) RepliCel Life Sciences Inc. - The Life Sciences Report Interview with Alan Leong More >
"CTRV's experienced management team knows how to present well, and investors are responding." (3/4/15) ContraVir Pharmaceuticals Inc. - The Life Sciences Report Interview with Alan Leong More >
"CANF's oral psoriasis candidate has shown some very, very promising data." (1/27/15) Can-Fite BioPharma Ltd. - The Life Sciences Report Interview with Reni Benjamin More >
"There is opportunity for the FDA to accept a new drug application filing from SNSS." (1/27/15) Sunesis Pharmaceuticals Inc. - The Life Sciences Report Interview with Mara Goldstein More >
"If all goes well, CUR's NSI-189 product will move into Phase 2 development in Q2/15, so that is a good advancement opportunity." (1/22/15) Neuralstem Inc. - The Life Sciences Report Interview with Edward Stopke More >
Companies
| Last: | |||
| Change: | Change(%): | ||
| Volume: | Open: | ||
| High: | Low: | ||
| 52Wk High: | 52Wk Low: | ||
Teva Pharmaceutical Industries Ltd.TICKER: NYSE:TEVA
|
A summary of Expert Comments about Teva Pharmaceutical Industries Ltd. is currently unavailable. You can find Expert Comments on companies similar to Teva Pharmaceutical Industries Ltd. by clicking on the links below.